Mostrar el registro sencillo del ítem

dc.contributor.authorCarelli, Valerio
dc.contributor.authorHirano, Michio
dc.contributor.authorEnriquez, Jose Antonio 
dc.contributor.authorChinnery, Patrick F
dc.date.accessioned2022-07-07T11:32:38Z
dc.date.available2022-07-07T11:32:38Z
dc.date.issued2021-11-02
dc.identifier.citationNat Rev Genet. 2021.es_ES
dc.identifier.urihttp://hdl.handle.net/20.500.12105/14686
dc.description.abstractIndividual cells in the same induced pluripotent stem cell (iPSC)-derived clones can exhibit large heterogeneity. In this Comment, Carelli et al. discuss emerging evidence implicating variants in mitochondrial DNA, and highlight the need for routine screening of iPSCs. Single-cell analyses in recent years have shown major differences in the transcriptome between individual cells in the same induced pluripotent stem cell-derived clones. Although these differences are in part attributable to genetic and epigenetic modifications of the nuclear genome, emerging evidence suggests that variants in mitochondrial DNA also play a pivotal role.es_ES
dc.description.sponsorshipV.C. is supported by the University of Bologna and the IRCCS Istituto delle Scienze Neurologiche. M.H. is supported by the National Institutes of Health (NIH U54 NS078059) and Marriott Mitochondrial Disease Clinic Research Fund (MMDCRF) from the J. Willard and Alice S. Marriott Foundation. J.A.E. is supported by the Centro de Investigacion Biomedica en Red en Fragilidad y Envejecimento Saludable (CIBERFES16/10/00282) and Severo Ochoa Program for Centers of Excellence to CNIC (SEV-2015-0505). P.F.C. is a Wellcome Trust Principal Research Fellow (212219/Z/18/Z) in the Medical Research Council Mitochondrial Biology Unit (MC_UU_00015/9). This research was supported by the NIHR Cambridge Biomedical Research Centre (BRC-1215-20014). The views expressed are those of the author(s) and not necessarily those of the NIHR or the Department of Health and Social Care.es_ES
dc.language.isoenges_ES
dc.type.hasVersionVoRes_ES
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.subjectiPSes_ES
dc.subjectMtDNAes_ES
dc.titleImplications of mitochondrial DNA mutations in human induced pluripotent stem cells.es_ES
dc.typejournal articlees_ES
dc.rights.licenseAttribution-NonCommercial-NoDerivatives 4.0 Internacional*
dc.identifier.pubmedID34728812 es_ES
dc.format.volume23es_ES
dc.format.number2es_ES
dc.format.page69-70es_ES
dc.identifier.doi10.1038/s41576-021-00430-zes_ES
dc.description.peerreviewedes_ES
dc.identifier.e-issn1471-0064es_ES
dc.identifier.journalNature reviews. Geneticses_ES
dc.repisalud.orgCNICCNIC::Grupos de investigación::Genética Funcional del Sistema de Fosforilación Oxidativaes_ES
dc.repisalud.institucionCNICes_ES
dc.rights.accessRightsopen accesses_ES


Ficheros en el ítem

Acceso Abierto
Thumbnail

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem

Attribution-NonCommercial-NoDerivatives 4.0 Internacional
Este Item está sujeto a una licencia Creative Commons: Attribution-NonCommercial-NoDerivatives 4.0 Internacional